Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain
Introduction
Status epilepticus (SE) selectively disrupts the integration of adult-generated hippocampal granule cells (Parent et al., 2006, Jessberger et al., 2007, Walter et al., 2007, Kron et al., 2010, Santos et al., 2011). Changes include mossy fiber axon sprouting, formation of hilar basal dendrites and ectopic migration of newly-generated cells. These phenomena have been implicated in promoting hyperexcitability in the temporal lobe and may facilitate epileptogenesis (Jung et al., 2004, Jung et al., 2006, Cho et al., 2015). Hilar ectopic granule cells, for example, are more excitable in rodent epilepsy models (Zhan et al., 2010, Althaus et al., 2015) and can exhibit both spontaneous and evoked bursting (Scharfman et al., 2000, Cameron et al., 2011), distinguishing them from normal granule cells. In addition to ectopically-located cells, granule cells with mossy fiber axon sprouting to the dentate inner molecular layer and hilar-projecting basal dendrites mediate the formation functional granule cell to granule cell synapses (Okazaki et al., 1999, Thind et al., 2008). These synaptic connections may mediate increased excitatory flow through the dentate gyrus. Despite the evidence that these abnormalities may contribute to epileptogenesis and associated comorbidities, no current FDA-approved treatments can prevent the aberrant integration of adult-generated neurons in epilepsy.
Recently, the mTOR pathway has emerged as a promising molecular target that may mediate aberrant granule cell integration. mTOR signaling in the dentate is enhanced in chemical, injury-induced and genetic models of epilepsy (Wong, 2013, LaSarge and Danzer, 2014), suggesting the pathway could be involved in many different forms of the disease. Treatment with rapamycin, an inhibitor of mTOR complex 1, has been shown to reduce seizures (Zeng et al., 2009, Huang et al., 2010, van Vliet et al., 2012), prevent mossy fiber sprouting (Zeng et al., 2009, Huang et al., 2010, Buckmaster et al., 2009, Buckmaster and Lew, 2011, Tang et al., 2012, van Vliet et al., 2012, Heng et al., 2013, Shima et al., 2015), mitigate cell loss (Zeng et al., 2009, van Vliet et al., 2012, Guo et al., 2013, Butler et al., 2015) and reduce reactive astrogliosis (Shima et al., 2015) in rodent modes of acquired epilepsy. Conversely, recent work from our lab demonstrates that genetically enhancing mTOR signaling by PTEN deletion in adult-generated hippocampal granule cells causes mossy fiber axon sprouting, formation of hilar basal dendrites and ectopic cell migration (Pun et al., 2012). We hypothesized, therefore, that mTOR hyperactivation underlies the cellular abnormalities evident in the hippocampus following status epilepticus.
To test our hypothesis we utilized rapamycin to directly inhibit mTOR activity in mice following pilocarpine-induced status epilepticus. A genetic fate-mapping strategy was used to determine the effectiveness of rapamycin at mitigating cellular abnormalities among adult-generated granule cells. In addition, mossy cell survival and reactive astrocytosis were examined in the animals, since these changes have also been implicated in epileptogenesis. These experiments provide new insights into the role of mTOR signaling in the formation of epilepsy-induced anatomical changes within the dentate gyrus.
Section snippets
Animals
All procedures involving animals were approved by the Institutional Animal Care and Use Committee of the Cincinnati Children's Hospital Research Foundation and conform to NIH guidelines for the care and use of animals. Two animal breeding schemes were followed: (1) In order to generate Gli1-CreERT2::GFP mice on a pure C57BL/6NCrl background for the study, hemizygous Gli1-CreERT2 mice (Ahn and Joyner, 2004, Ahn and Joyner, 2005) on a C57BL/6NCrl background were crossed to homozygous CAG-CAT-EGFP
Results
To induce the development of epilepsy, mice were treated with the cholinergic agonist pilocarpine to provoke status epilepticus (SE), which was allowed to proceed for 3 h before seizures were mitigated by treatment with diazepam. Control animals received saline instead of pilocarpine. Studies were begun using C57BL/6NCrl mice. Because of high mortality during the 24 h period following SE, however, mice on a 50:50 background of C57BL/6NCrl::FVB N (B6/FVB) were also used. B6/FVB mice showed
Discussion
mTOR signaling is enhanced during the development of acquired temporal lobe epilepsy (Fig. 1), and rapamycin treatment has been shown to reduce seizures frequency in a variety of epilepsy models, including kainate-SE (Zeng et al., 2009), pilocarpine-SE (Huang et al., 2010), angular bundle electrical stimulation (van Vliet et al., 2012), neonatal hypoxia (Talos et al., 2012), traumatic brain injury (Guo et al., 2013), models of TSC (Zeng et al., 2008, Goto et al., 2011, Zeng et al., 2011) and
Conflict of interests
The authors declare no competing financial interests.
Acknowledgments
This work was supported by the National Institute of Neurological Disorders and Stroke (SCD, Award Numbers R01NS065020 and R01NS062806). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. We thank Keri Kaeding for assistance with earlier versions of this manuscript. We thank the CCHMC Confocal Core for providing access the 3024 Nikon
References (119)
- et al.
Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning
Cell
(2004) - et al.
Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model
Exp. Neurol.
(2003) - et al.
Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin
Neurobiol. Dis.
(2012) - et al.
Duration of rapamycin treatment has differential effects on metabolism in mice
Cell Metab.
(2013) - et al.
Mossy cells in the mouse dentate gyrus: identification in the dorsal hilus and their distribution along the dorsoventral axis
Brain Res.
(1999) - et al.
The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation
Kidney Int.
(2010) - et al.
Contributions of astrocytes to epileptogenesis following status epilepticus: opportunities for preventive therapy?
Neurochem. Int.
(2013) - et al.
Rapamycin increases neuronal survival, reduces inflammation and astrocyte proliferation after spinal cord injury
Mol. Cell. Neurosci.
(2015) - et al.
Hippocampal granule cell pathology in epilepsy — a possible structural basis for comorbidities of epilepsy?
Epilepsy Behav.
(2014) - et al.
Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
Neurobiol. Dis.
(2010)
Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats
Neuroscience
Obesity in adults with epilepsy
Epilepsy Behav.
Stereological analysis of GluR2-immunoreactive hilar neurons in the pilocarpine model of temporal lobe epilepsy: correlation of cell loss with mossy fiber sprouting
Exp. Neurol.
Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
Neurobiol. Dis.
PTEN deletion from adult-generated dentate granule cells disrupts granule cell mossy fiber axon structure
Neurobiol. Dis.
Inhibition of mTOR pathway restrains astrocyte proliferation, migration and production of inflammatory mediators after oxygen–glucose deprivation and reoxygenation
Neurochem. Int.
Epilepsy and hormones: a critical review
Epilepsy Behav.
Is the ketogenic diet effective in specific epilepsy syndromes?
Epilepsy Res.
The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial
Lancet Neurol.
Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy
Neuron
Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons
Epilepsy Res.
Metabolic gene expression changes in the hippocampus of obese epileptic male rats in the pilocarpine model of temporal lobe epilepsy
Brain Res.
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy
Neuropharmacology
Contributions of mature granule cells to structural plasticity in temporal lobe epilepsy
Neuroscience
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
Mol. Cell
Strain differences in seizure-induced cell death following pilocarpine-induced status epilepticus
Neurobiol. Dis.
Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy
Neurosci. Lett.
Changing channels in pain and epilepsy: exploiting ion channel gene therapy for disorders of neuronal hyperexcitability
FEBS Lett.
Molecular dissection of reactive astrogliosis and glial scar formation
Trends Neurosci.
Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis
Neurobiol. Dis.
Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: an emergent property of a complex system
Prog. Brain Res.
Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor
Neuroscience
In vivo analysis of quiescent adult neural stem cells responding to sonic hedgehog
Nature
Intrinsic neurophysiological properties of hilar ectopic and normotopic dentate granule cells in human temporal lobe epilepsy and a rat model
J. Neurophysiol.
Recurrent excitation of granule cells with basal dendrites and low interneuron density and inhibitory postsynaptic current frequency in the dentate gyrus of macaque monkeys
J. Comp. Neurol.
Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage
PLoS ONE
Does mossy fiber sprouting give rise to the epileptic state?
Adv. Exp. Med. Biol.
Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy
J. Neurosci.
Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy
J. Neurosci.
Effects of rapamycin treatment on neurogenesis and synaptic reorganization in the dentate gyrus after controlled cortical impact injury in mice
Front. Syst. Neurosci.
Recent advances in adipose mTOR signaling and function: therapeutic prospects
Trends Pharmacol. Sci.
Morphologic integration of hilar ectopic granule cells into dentate gyrus circuitry in the pilocarpine model of temporal lobe epilepsy
J. Comp. Neurol.
Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy
Epilepsia
Impact of corticosterone treatment on spontaneous seizure frequency and epileptiform activity in mice with chronic epilepsy
PLoS ONE
Rapamycin has age-, treatment paradigm-, and model specific anticonvulsant effects and modulates neuropeptide Y expression in rats
Epilepsia
Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline
Nat. Commun.
Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy
Neurology
Rapamycin: brain excitability studied in vitro
Epilepsia
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
Oncogene
The Mouse in Biomedical Research: Normative Biology, Husbandry, and Models
Cited by (35)
Hippocampal glucocorticoid receptors modulate status epilepticus severity
2023, Neurobiology of DiseasePromise of extracellular vesicles for diagnosis and treatment of epilepsy
2021, Epilepsy and BehaviorCitation Excerpt :The efficacy of EVs to improve cognitive function and/or suppress spontaneous seizures in chronic epileptic conditions is yet to be investigated, however. Additionally, it remains to be addressed whether IN administration of EVs is efficacious for modulating abnormal long-term plasticity such as aberrant mossy fiber sprouting [62–64], the activation of the mammalian target of rapamycin (mTOR) pathway [65–67], or psychiatric comorbidities [58,59] associated with epilepsy. Extracellular vesicles are enriched with miRNAs, in comparison with non-EV fractions in the CSF or plasma.
The glucocorticoid receptor specific modulator CORT108297 reduces brain pathology following status epilepticus
2021, Experimental NeurologyCitation Excerpt :Serial sections were collected into wells containing cryoprotectant solution (30% sucrose, 1% polyvinylpyrrolidone, 30% ethylene glycol in 0.1 M PBS) and stored at −20 °C. Free floating brain sections were placed in blocking solution (4% normal goat serum, 0.1% bovine serum albumin and 0.2%Triton-X in 0.1 M PBS) for 1 h and subsequently immunostained for 24 h at 4 °C with the following antibodies: rabbit anti-Fos (1:500 Santa Cruz Biotechnology, RRID: AB_2106783; (Wulsin et al., 2010)) mouse anti-NeuN (1:500 Millipore, RRID:AB_2298772; (Figueiredo et al., 2003)), rabbit anti-Prox1 (Sigma-Aldrich, 1:100, RRID: AB_1079691; (Murphy et al., 2012)), chicken anti-GFAP (Abcam, 1:1000, RRID: AB_304558), rabbit anti-GluR2/3 (Millipore, 1:100, RRID: AB_310741; (Hester and Danzer, 2013)) and rabbit anti-Iba1 (Synaptic Systems, 1:1000; (Hester et al., 2016; Smith et al., 2016)). Donkey anti-rabbit AlexaFluor594 (1:500 Jackson ImmunoResearch Labs, RRID:AB_2340621), goat anti-mouse AF488 (1:500 Jackson ImmunoResearch Labs, RRID:AB_2307324), donkey anti-rabbit AF647, goat anti-rabbit AF488, goat anti-chicken AF488 and goat anti-rabbit AF594 (Life Technologies, 1:750) secondary antibodies were used to visualize the respective primary antibodies.
LncRNA CASC2 inhibits astrocytic activation and adenosine metabolism by regulating PTEN in pentylenetetrazol-induced epilepsy model
2020, Journal of Chemical NeuroanatomyIntergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism
2019, Trends in NeurosciencesCitation Excerpt :The latter study provided evidence that S6 kinase (a target of mTOR) is hyperphosphorylated in somatosensory cortex of MECP2 transgenic mice, consistent with a role for hyperactivation of the mTOR pathway in developmental abnormalities. Because hyperactivation of the mTOR pathway in brain cells and ASD-like synaptic and behavioral abnormalities occur in animals fed diets high in sucrose or saturated fat [10,57–59], the findings that genetic manipulations that increase mTOR pathway activity result in ASD-like behavioral abnormalities support the metabolic syndrome hypothesis of ASD. Several ASD mouse models directly impact proteins that regulate neuronal excitability and cell growth.
- 1
These authors contributed equally to this work.